Live virtual event
May 20, 2025 | 11 AM鈥�12 PM ET
60 minutes
Biological & Medicinal Chemistry
Physical Chemistry
Safety
Analytical Chemistry
Oncology therapeutics continue to lead FDA and EMA approvals year over year, with drug discovery services in oncology predicted to have a 15% CAGR this year. Regardless of your tumor type focus, or whether your therapeutic approach involves small molecules, antibody-drug conjugates (ADCs), or immunotherapies, Eurofins Discovery is your partner of choice.
We provide Integrated Drug Discovery solutions to help your journey from idea to IND. With a strong team of scientific experts and program managers, we work with you to design your oncology pathway to seamlessly increase your chance of success. Through this webinar, you鈥檒l learn how we are addressing the challenges of oncology drug discovery and supporting programs with our 12,000+ in vitro assays, key services, and the tools needed to advance both monotherapies and combination approaches in the fight against cancer.
Alastair J. King, Ph.D.
Head of Biology, Eurofins Discovery
Michele Modugno, M.Sc.
Scientific Project Lead (Biology), Eurofins Discovery
Keep learning. Excel in your career.
Choose from more than 200 courses in seven different categories, taught by experts in the chemistry community, online and in person.
Copyright © 2025 American Chemical 中国365bet中文官网
;void(0);){kind=link}